EXCLUSIVE: Avalon GloboCare Tells Benzinga 'Device is Approved for Reimbursement by Medicare and is Supported by Several Private Insurance Providers'
Portfolio Pulse from Benzinga Newsdesk
Avalon GloboCare announced that its device has been approved for reimbursement by Medicare and is supported by several private insurance providers.
August 14, 2024 | 11:30 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalon GloboCare's device has received approval for reimbursement by Medicare and is supported by several private insurance providers, which is likely to boost the company's revenue and market position.
The approval for Medicare reimbursement and support from private insurers is a significant milestone for Avalon GloboCare. This development is likely to increase the adoption of their device, leading to higher revenues and a stronger market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100